Asia-Pacific Advanced Visualization Market was worth USD 0.37 billion in 2018 and estimated to be growing at a CAGR of 13%, to reach USD 0.68 billion by 2023. Advanced visualization has a good market since it acts as a tool for Computed Tomography, Positron Emission Tomography. The advanced visualization market has been mainly limited to radiologists in the past, but in these days, it is applicable to Orthopedics, Cardiac, Neurology, Oncology, Vascular, Neurology and Others.
Computed Tomography continues to attract the larger share of research and development efforts in the AV industry, with MRI in a strong second place, followed by positron emission tomography and nuclear medicine. Mirroring the technology and market development of hybrid imaging systems, there is large market for Advanced Visualization. Inventions with more powerful clinical application are looking in every area where these imaging modalities are evolving in the areas of radiology, cardiology, neurology, orthopedics and oncology.
Massive number of ongoing innovations and developments in the healthcare and imaging sectors, rising spending capabilities and the ease of use of medical imaging devices, the rising occurrences of target diseases amongst all civilians, all these factors have driven to the increased adoption of the technology in turn increasing the growth. However, there are some restraints in the market like Hacking technology, Lack of skilled professionals and aspects of cost effective.
The Asia-Pacific Advanced Visualization Market by Product and Services (Hardware and Software), by Solution (Standalone and Enterprise), by Imaging Modality (Magnetic Resonance Imaging (MRI), Computed Tomography (CT), Positron Emission Tomography (PET), Ultrasound, Radiotherapy (RT), Nuclear Medicine, Others (PET and SPECT), by Clinical Application(Radiology, Orthopedics, Cardiac, Neurology, Oncology, Vascular, Neurology, Others), by End user(Hospitals and Surgical Centres, Imaging Centres , Academic and Research Centres and others).
The Asia-Pacific region is geographically segmented into China, India, Japan, South Korea, and Australia. Asia-Pacific is one of the most developing markets in the world. As of 2016, the Asia-Pacific accounting of 16% share in global advanced visualization in all the segments. Factors such as growing economy in countries like India and China, the increase in imaging facility, and Huge Population in China, India and Australia has driven huge amount of market in this region.
They are big and developing companies operating in this region. Some of the major companies dominating the market, by their products and services include General Electric Company, Canon Inc, Siemens AG, Koninklijke Philips N.V, Fujifilm Holdings Corporation, Toshiba Corporation, Terarecon, Inc., Carestream Health, Inc., Pro Medicus Limited, Ziosoft, Agfa-Geveart N.V, and Qi Imaging, LLC.
1.Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemology
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 Product and Services
5.1.1 Introduction
5.1.2 Hardware
5.1.3 Software
5.1.4 Services
5.1.5 Y-o-Y Growth Analysis, By Product and services
5.1.6 Market Attractiveness Analysis, By Products and services
5.1.7 Market Share Analysis, By Products and services
5.2 Solution
5.2.1 Introduction
5.2.2 Standalone
5.2.3 Enterprise
5.2.4 Y-o-Y Growth Analysis, By Solution
5.2.5 Market Attractiveness Analysis, By Solution
5.2.6 Market Share Analysis, By Solution
5.3 Imaging Modality
5.3.1 Introduction
5.3.2 Magnetic Resonance Imaging (MRI)
5.3.3 Computed Tomography (CT)
5.3.4 Positron Emission Tomography (PET)
5.3.5 Ultrasound
5.3.6 Radiotherapy (RT)
5.3.7 Nuclear Medicine
5.3.8 Others (PET and SPECT)
5.3.9 Y-o-Y Growth Analysis, By Imaging Modality
5.3.8 Market Attractiveness Analysis, By Imaging Modality
5.3.9 Market Share Analysis, By Imaging Modality
5.4 Clinical Application
5.4.1 Introduction
5.4.2 Radiology
5.4.3 Orthopedics
5.4.4 Cardiac
5.4.5 Neurology
5.4.6 Oncology
5.4.7 Vascular
5.4.8 Neurology
5.4.9 Other diseases
5.4.10 Y-o-Y Growth Analysis, By Clinical Application
5.4.11 Market Attractiveness Analysis, By Clinical Application
5.4.12 Market Share Analysis, By Clinical Application
5.5 End user
5.5.1 Hospitals and Surgical centres
5.5.2 Imaging Centres
5.5.3 Academic and Research Centres
5.5.4 Others
5.5.5 Y-o-Y Growth Analysis, By End user
5.5.6 Market Attractiveness Analysis, By End user
5.5.7 Market Share Analysis, By End user
6. Geographical Analysis
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Geographical Area
6.1.3.2 By Product and Services
6.1.3.3 By Solution
6.1.3.4 By Imaging Modality
6.1.3.5 By Clinical Application
6.1.3.6 By End user
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Geographical Area
6.1.4.2 By Product and Services
6.1.4.3 By Solution
6.1.4.4 By Imaging Modality
6.1.4.5 By Clinical Application
6.1.4.6 By End user
6.1.5 Market Share Analysis
6.1.5.1 By Geographical Area
6.1.5.2 By Product and Services
6.1.5.3 By Solution
6.1.5.4 By Imaging Modality
6.1.5.5 By Clinical Application
6.1.5.6 By End user
6.2 China
6.3 India
6.4 Japan
6.5 South Korea
6.6 Australia
7.Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8.Market Leaders' Analysis
8.1 General Electric Company
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 Canon Inc
8.3 Siemens AG
8.4 Koninklijke Philips N.V.
8.5 Fujifilm Holdings Corporation
8.6 Toshiba Corporation
8.7 Terarecon Inc
8.8 Carestream Health, Inc
8.9 Pro Medicus Limited
8.10 Ziosoft
8.11 Agfa-Geveart N.V.
8.12 Qi Imaging, LLC
9.Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10.Market Outlook and Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
